Affymax Market Cap: 372.21M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
None selected
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
AFFY Market Cap Rankings
| Overall | 43rd percentile | 2640 of 4673 |
| Sector | 58th percentile | 218 of 530 in Healthcare |
| Industry | 69th percentile | 50 of 164 in Biotechnology |
AFFY Market Cap Range, Past 5 Years
| Minimum | 487.11M | Dec 2006 |
| Maximum | 487.11M | Dec 2006 |
| Average | 487.11M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
You may also be interested in these AFFY related companies
AFFY News
$AFFY CEO will present at the 14th Annual BIO CEO & Investor Conference on Tuesday, February 14 @ 3:00 p.m EST.
about 3 days ago by abubnic
about 3 days ago by abubnic
@Trading4Cash I sold my PP at the close, same thing, made$$, I kind of regret selling my $affy one day early but go in early on that too!
about 8 days ago by professorkev
about 8 days ago by professorkev
@EXPstocktrader Are you on $AFFY too? Analyst have a $19 price target on it.
about 9 days ago by MaddStocks
about 9 days ago by MaddStocks
great run up in $AFFY this was the last squeeze as shorts took over for the time being. Locked in 10.45 reestablishing another entry
about 9 days ago by ACE52WeekHigh
about 9 days ago by ACE52WeekHigh
$AFFY Shares Given New $19.00 Price Target by Piper Jaffray Analysts. http://stks.co/2EAA
about 9 days ago by abubnic
about 9 days ago by abubnic
Affymax Promotes Cynthia Smith to Vice President, Market Access and Commercial Development
Feb 02, 4:00PM Business Wire
Feb 02, 4:00PM Business Wire
$AFFY beautiful. Approaching a beautiful rip towards $10. Vacuum buying in the mix!!!
about 10 days ago by ACE52WeekHigh
about 10 days ago by ACE52WeekHigh
Piper Jaffray Raises Target on Affymax (AFFY) to $19 Amid Optimistic Peginesatide Numbers
Feb 02, 11:40AM Street Insider
Feb 02, 11:40AM Street Insider
Baird Maintains an 'Outperform' on Affymax (AFFY); Even After Significant Model Revamp, It's Still A Buy
Dec 29, 7:07AM Street Insider
Dec 29, 7:07AM Street Insider
Takeda Pharmaceutical and Affymax (AFFX) Make Decision Not to Commercialize Peginesatide in Japan
Dec 15, 4:05PM Street Insider
Dec 15, 4:05PM Street Insider
Takeda and Affymax Provide Update on Peginesatide Commercialization Rights in Japan
Dec 15, 4:03PM Benzinga
Dec 15, 4:03PM Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| AFFY | 10.47 | -0.06 | -0.57% | 372.21M |
| CMLS | 3.79 | 0.00 | 0.00% | 199.01M |
| EBAY | 33.02 | -0.23 | -0.71% | 42.63B |
| HILL | 1.45 | -0.03 | -2.03% | 83.07M |
| NWSA | 19.18 | -0.04 | -0.18% | 33.02B |
| EDAP | 2.11 | -0.04 | -1.86% | 27.68M |
| GSAT | 0.74 | 0.05 | 7.23% | 216.88M |
| ELNK | 7.94 | -0.09 | -1.12% | 855.77M |
| JRCC | 6.38 | -0.51 | -7.40% | 227.13M |
| JNPR | 22.72 | -0.46 | -1.98% | 12.11B |
